News

Sogroya acts as a replacement for endogenous growth hormone and is administered once a week to support growth in children with the condition. NICE’s recommendation provides families and healthcare ...
About Paediatric Growth Hormone Deficiency Paediatric growth hormone deficiency (GHD) is a serious orphan disease caused when the pituitary gland does not produce enough growth hormone.
Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the Australian registration of SKYTROFA® (lonapegsomatropin) as a new once-weekly injectable therapy for ...
A deficiency in growth hormone can affect the development of your skeleton and muscles. Learn about symptoms, causes, and treatment in children and adults.
Parents in Korea are paying up to 10 million won ($6,800) a year for growth hormone injections given nightly for up to three years In South Korea, height is increasingly seen not just as a ...
Research reveals how sleep quality, exercise intensity, nutrition timing, and stress management can naturally optimize growth hormone production.
Growth hormone therapy was initiated for 20 children-14 diagnosed with Turner syndrome and six with GH deficiency-under the Centre of Excellence for Rare Diseases. A multidisciplinary team ...
Health Minister Veena George on Friday announced the launch of growth hormone (GH) treatment under the State’s KARE (Kerala United Against Rare Diseases) scheme, marking a significant step in ...
What is the best age to start growth hormone treatment? “The optimal age for starting growth hormone therapy depends on the underlying cause of the growth issue,” Waikar says.
Human growth hormone (HGH) is a hormone that’s essential to our development. Most people produce enough HGH throughout their lifetime. But for those with a deficiency in growth hormone (or a few ...
Lonapegsomatropin is currently approved under the brand name Skytrofa ® for the treatment of pediatric patients 1 year and older who weigh at least 11.5kg and have a growth failure due to ...
Researchers review the biological activities of growth hormone-releasing hormone and its analogs.